MedTrace Logo

Efficacy of the Nanodropper Device on Pupillary Dilation

NCT05274321 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-09-25

Study results available
· View outcomes & findings →

Summary

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.

Conditions

  • Dilation

Interventions

DEVICE

Nanodropper

Device used for administering eye drops

DEVICE

Standard Eye Dropper

Standard Eye Dropper used for administering eye drops

Sponsors & Collaborators

Principal Investigators

  • Julius Oatts, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-29
Primary Completion
2021-11-19
Completion
2021-11-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274321 on ClinicalTrials.gov